Google Chrome
Safari
Firefox
Edge
Continuous Manufacturing of Oral Solid Dosage Forms
Date:
2024/04/16
to 2024/04/18
Location:
Portugal
Search
Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
Press Release / Mar 22, 2023
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon Medical’s 3D screen printing technology.
Press Release / Mar 18, 2024
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Press Release / May 06, 2025
Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer
Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Carcinoma - the third leading cause of cancer-related deaths worldwide
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs